Tuberculosis
Laboratory Diagnosis and Treatment Strategies
Published on 25. April 2013
978-1-78924-467-0 (ISBN)
Description
Tuberculosis is a global health threat and the unique features of Mycobacterium tuberculosis and emergence of drug-resistant strains highlight the challenge it presents. Covering a wealth of state-of-the-art knowledge from active international experts, this book captures the latest developments in the advent of bacteriological, immunological and molecular tools for diagnosis and the development of new drugs. It shows how the challenge of tuberculosis is currently being met, providing insight into the evidence base underlying new developments in diagnosis, drug development and treatment.
More details
Series
Language
English
Place of publication
Wallingford
United Kingdom
Target group
College/higher education
Professional and scholarly
File size
4,41 MB
ISBN-13
978-1-78924-467-0 (9781789244670)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Book
04/2013
CABI Publishing
€223.50
Shipment within 3-4 weeks
Persons
Editor
University College London, UK
Contributions
World Health Organization, Switzerland
NHS Trust, UK
Universidade Nova de Lisboa, Portugal
National Jewish Health, USA
Imperial College London, UK
University College London, UK
Novartis Institute for Tropical Diseases, Singapore
London School of Hygiene and Tropical Medicine, UK
National Institute for Public Health and the Environment (RIVM), The Netherlands
Content
I: Introduction Part I: Diagnosis 1: Improving on Sputum Smear Microscopy for Diagnosis of Tuberculosis in Resource-poor Settings 2: Molecular Diagnosis of Active Pulmonary Tuberculosis 3: Improving on the LJ slope - Automated Liquid Culture 4: Interferon-gamma Release Assays in the Diagnosis of Latent Tuberculosis Infection 5: Measuring Tuberculosis Immune Responses in the Lung - The Correct Target? 6: Sniffing Out Tuberculosis Part II: Measuring Resistance 7: Role of Phenotypic Methods for Drug Susceptibility Testing of M. tuberculosis Isolates in the Era of MDR and XDR Epidemics 8: Genotypic Measures of Antibiotic Susceptibility 9: Molecular Tools for Fast Identification of Resistance and Characterization of MDR/XDR-TB Part III: Understanding Treatment 10: Monitoring Therapy by Bacterial Load 11: Modelling Responses to Tuberculosis Treatment 12: Measuring Gene Expression by Quantitative PCR (qPCR) 13: Transcriptomic Approaches to Mapping Responses to Drug Therapy for Tuberculosis 14: Mycobacterial Lipid Bodies and Resuscitation-promoting Factor Dependency as Potential Biomarkers of Response to Chemotherapy Part IV: Treatment Strategies 15: Clinical Trials in Tuberculosis Chemotherapy: The Challenges 16: The Identification of 2-Aminothiazole-4-carboxylates (ATCs) as a New Class of Tuberculosis Agent: A Lesson in 'HIT' Identification 17: Rifamycins Revisited 18: Therapy of the XDR-TB Patient with Thioridazine - An Old Drug with New Applications 19: Vaccines for Tuberculosis
